# Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393

> **NCT05274880** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 28 (actual)

## Conditions studied

- Type II Diabetes Mellitus

## Interventions

- **DRUG:** CKD-393

## Key facts

- **NCT ID:** NCT05274880
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-21
- **Primary completion:** 2022-07-15
- **Final completion:** 2022-07-26
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2022-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05274880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05274880, "Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05274880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*